Identify the regulatory ownership event
A seller of a Medicare-participating provider cannot determine the provider agreement’s treatment solely from the transaction’s tax classification. The applicable program rules define ownership changes and attach consequences to the actual legal structure. Identify the provider entity, agreement, facility, and proposed sequence early enough to coordinate the regulatory path with the purchase agreement.
Under 42 CFR 489.18, a qualifying ownership change generally produces automatic assignment of the existing provider agreement. The regulation distinguishes entity transactions: transferring corporate stock or merging another corporation into the provider corporation does not constitute an ownership change under this provision, while specified mergers or consolidations creating a different provider entity do. It also addresses partnerships, sole proprietorships, and leasing. A provider contemplating or negotiating an ownership change must notify CMS.
Those distinctions do not eliminate other enrollment, disclosure, approval, or provider-specific requirements. Give the enrollment team the full transaction structure rather than asking whether an asset sale or stock sale is generally simpler. The applicable result should be documented for the actual provider and steps.
Compare continuity with the consequences of rejection
CMS’s published acquisition guidance explains that a new owner may reject automatic assignment. Rejection terminates the prior agreement and makes the facility an initial applicant if it seeks Medicare participation. CMS warns of an uncertain period without Medicare payments in that situation. A buyer should not describe rejection as a paperwork reset with guaranteed immediate replacement participation.
Consider a hypothetical provider with $280,000 of monthly collections attributable to the relevant Medicare activity and $210,000 of monthly costs that continue during an interruption. If the transaction model assumes an illustrative two-month period without those collections, the immediate funding question could involve $420,000 of continuing costs before other receipts and expense changes. This is a planning scenario, not a prediction of enrollment timing or a determination that particular services will later be reimbursed.
The seller should know whether the buyer’s financing and price depend on accepting assignment or pursuing initial participation. Put that decision into the contract and liquidity review. Do not assume that an agreed closing date controls the government’s participation effective date.
Review what follows the assigned agreement
The regulation states that an assigned agreement remains subject to applicable law and its original terms and conditions, including an existing plan of correction and health and safety requirements. The buyer therefore needs more than a copy of the agreement’s identification number. Assemble the relevant compliance history and unresolved matters so the parties can evaluate what accompanies continuity.
Ask counsel and the enrollment specialists to distinguish program obligations from the parties’ contractual allocation of responsibility. An indemnity can allocate economic risk between seller and buyer, but it does not automatically alter how CMS applies its rules. Specify who will respond to requests, maintain records, and address matters spanning the closing date.
Coordinate claims, receivables, adjustments, and cash receipts through a supported cutoff process. A balance in the seller’s ledger is not by itself proof of which entity may bill, receive, or retain a payment after the transaction. The parties should establish the actual rules and document how postclosing reconciliations will be handled without interrupting necessary patient services.
Keep a provider-specific transition file
Retain entity diagrams, agreement records, enrollment submissions, notices, CMS and contractor correspondence, compliance schedules, and the documented acceptance or rejection decision. Track each required action by responsible person and due date. Include the evidence supporting the participation effective date and operational transition rather than relying on the anticipated closing timetable alone.
CMS’s guidance cautions against assuming the timing of an initial certification survey or participation date. The financial model should therefore contain a delay scenario and a source of funds that is actually available. Update the model when the relevant agency or contractor provides a determination, and preserve the changed assumptions for the final working capital reconciliation.
This guide addresses the general provider-agreement ownership rule and CMS’s published rejection guidance. Particular provider and supplier categories can have additional change-in-ownership or majority-ownership restrictions, and state licensing, Medicaid, accreditation, and other payer agreements require separate review. Obtain a coordinated determination for the provider being sold. The useful outcome is an ownership sequence and cash plan that accurately reflect the chosen participation path, supported by a complete record of the obligations and actions carried through closing.
Sources & further reading
Consult the original guidance and its effective dates. These references support the educational discussion; their application depends on the specific facts.